SLD (SLD) News
Follow SLD (SLD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Saluda Medical Initiates Voluntary Field Action for Certain Evoke Devices
EQUITY | Oct 21, 2026, 01:01 AM UTC
M
Saluda Medical Recalls Some Evoke Devices After Manufacturing Issue
Saluda Medical said it is voluntarily recalling certain Evoke neurostimulation devices after identifying a manufacturing-related issue. Its shares fell to a record low.
EQUITY | Oct 21, 2026, 12:59 AM UTC
L
Saluda Medical appoints Mike Mathias as CEO, replacing Barry Regan
Saluda Medical appointed Mike Mathias as CEO, replacing Barry Regan.
EQUITY | Sep 07, 2026, 08:20 AM UTC
L
Saluda Medical price target cut to A$2.17 by Morgans
Morgans cut its price target for Saluda Medical 26% to A$2.17 per share.
EQUITY | Sep 02, 2026, 11:06 PM UTC
L
Canaccord Genuity lifts Saluda Medical price target 1% to A$2.02
Canaccord Genuity raised its Saluda Medical price target by 1% to A$2.02 per share.
EQUITY | Aug 31, 2026, 01:07 AM UTC
L
Saluda Medical sees FY27 revenue growth 25%-35% vs FY26
Saluda Medical expects FY27 revenue to grow between 25% and 35% versus FY26.
EARNINGS | Aug 28, 2026, 01:39 AM UTC
L
Saluda Medical posts FY26 revenue from ordinary activities
Saluda Medical posted FY26 revenue from ordinary activities of $90.2 million.
EQUITY | Aug 28, 2026, 01:36 AM UTC